Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 1—January 2004
Research

Escherichia coli Producing CTX-M-2 β-Lactamase in Cattle, Japan

Yutaka Shiraki*Comments to Author , Naohiro Shibata†, Yohei Doi†, and Yoshichika Arakawa†
Author affiliations: *Gifu Prefectural Office of Meat Inspection, Gifu, Japan; †National Institute of Infectious Diseases, Tokyo, Japan

Main Article

Table 2

MICs of β-lactams for Escherichia coli strains isolated from cattle, transconjugants, and recipientsa

MIC (μg/mL) for E. coli strain:
Antimicrobial drug GS528 CSH2
trGS528 GS554 CSH2
trGS554 CSH2
Piperacillin >64 >64 >64 >64 <16
Cefotaxime >128 >128 >128 >128 <0.5
Cefotaxime + CLAb <0.12 <0.12 32 32 <0.12
Ceftazidime 2 4 32 32 <0.5
Ceftazidime + CLA <0.12 <0.12 16 32 <0.12
Aztreonam >64 64 >64 64 <0.5
Ceftriaxone >64 >64 >64 >64 <0.5
Cefpodoxime >64 >64 >64 >64 <0.5
Cefepime >32 >32 >32 >32 <1
Cefotetan <0.5 <0.5 >32 >32 <0.5
Cefmetazole 1 1 >16 >16 1
Cefoxitin <2 <2 >32 >32 <2
Meropenem <0.5 <0.5 8 4 <0.5
Ceftiofur >1,024 >1,024 >1,024 >1,024 <0.25

aE. coli CSH2 trGS528 and trGS554 were transconjugants of E. coli GS528 and GS554, respectively.
bCLA, clavulanic acid at a fixed concentration of 4 μg/mL.

Main Article

Page created: December 21, 2010
Page updated: December 21, 2010
Page reviewed: December 21, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external